𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial

✍ Scribed by Nicole Sherry; William Hagopian; Johnny Ludvigsson; Sunil M Jain; Jack Wahlen; Robert J Ferry Jr; Bruce Bode; Stephen Aronoff; Christopher Holland; David Carlin; Karen L King; Ronald L Wilder; Stanley Pillemer; Ezio Bonvini; Syd Johnson; Kathryn E Stein; Scott Koenig; Kevan C Herold; Anastasia G Daifotis


Book ID
117308771
Publisher
The Lancet
Year
2011
Tongue
English
Weight
397 KB
Volume
378
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES